Clinical Impact of a LAG3 Single-Nucleotide Polymorphism in Relapsed, Refractory DLBCL Patients Treated with Glofitamab

Authors

Martina Bertschinger (ORCID: https://orcid.org/0000-0003-1736-812X)
Henning Nilius (ORCID: https://orcid.org/0000-0002-1323-3116)
Katja Seipel (ORCID: https://orcid.org/0000-0003-3128-1573)
Vera Rentsch
Ulrike Bacher
Thomas Pabst
Maeva Ullmann

Institutions

University of Bern (CH)
University Hospital of Bern (CH)

Publication Details

Journal: Cancers
Published: 2026-03-13
DOI: https://doi.org/10.3390/cancers18060930
Primary Topic: Cancer Immunotherapy and Biomarkers
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Clinical Impact of a LAG3 Single-Nucleotide Polymorphism in Relapsed, Refractory DLBCL Patients Treated with Glofitamab

Martina Bertschinger, Henning Nilius, Katja Seipel, Vera Rentsch et al.

Mar 13, 2026

Cancers

Cancer Immunotherapy and Biomarkers

article

Clinical Impact of a LAG3 Single-Nucleotide Polymorphism in Relapsed, Refractory DLBCL Patients Treated with Glofitamab

Martina Bertschinger, Henning Nilius, Katja Seipel, Vera Rentsch, Ulrike Bacher, Thomas Pabst, Maeva Ullmann

March 13, 2026article en

Abstract

No abstract available for this paper.

CancersVol. 18(6)

University of Bern (CH), University Hospital of Bern (CH)

Good health and well-being

Openalex Percentile: Top 23%

Cancer Immunotherapy and Biomarkers

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Clinical Impact of a LAG3 Single-Nucleotide Polymorphism in Relapsed, Refractory DLBCL Patients Treated with Glofitamab — Martina Bertschinger, Henning Nilius, et al. · Cancers (2026) | TGRS Research Map | TGRS